MSD has two vaccines and has research in other areas. Vaccines for hepatitis-A, Chickenpox and rotavirus are on the agenda to be released soon. BD Even as global financial slowdown is forcing companies to retrench jobs, MSD Pharmaceuticals, a subsidiary of US-based Merck & Co, today...
The company has formed a “strategic partnership” with inVentiv Health , who does a lot of outsourcing for big Pharma, earlier this year, so perhaps some the sales and marketing slated for sales will be moving in this direction. Merck is not the only company investigating and pursuing this direction...
It appears from the article that the move is generated more towards called made on family practice physicians, as vaccines or drugs marketed to oncologists, ophthalmologists, or dermatologists will still be handled by in house sales representatives, so specialty drug representatives appear to be safe...
How much information is enough? It appears today that there's never enough to go around. Hopefully as the field of personalized medicine grows we will have more answers in the ability to predict and understand more about how different drugs work and what the projected outcomes will be...
Posted to
The Medical Quack .... by Barbara Duck
on 09-10-2008
Filed under: Medically Related, Pharma/FDA News, Physician, personalized medicine, Medicine, healthcare, Merck, Byetta, Januvia
The meaning of advantage is below. Who knows what might be uncovered next as this may or may not be just a Merck issue, but as documents and other items of years past surface, this is what we have, sell, sell, sell, and it's perhaps not unlikely that some of these items and issues could exist...
Update: Are 3 minds better than one? It certainly appears this could be the case, at least when it comes to clinical trials and getting the right type of participants to enroll and some forecasting to make sure the drugs will succeed. What is the target here, the big crystal...
The article relates to baby boomers, who were more likely to have engaged in oral sex with many partners in particular. One more reason perhaps to see if the vaccine can be more affordable for practices to provide for patients. Patients affected thus far were those born in the 1950s and after...